New Zealand markets close in 5 hours 57 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
142.39+3.89 (+2.81%)
At close: 04:02PM EST
142.72 +0.33 (+0.23%)
After hours: 05:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous close138.50
Bid141.06 x 800
Ask142.58 x 1000
Day's range138.09 - 142.69
52-week range130.96 - 168.11
Avg. volume4,796,955
Market cap251.395B
Beta (5Y monthly)0.48
PE ratio (TTM)38.90
EPS (TTM)3.66
Earnings date07 Feb 2024 - 12 Feb 2024
Forward dividend & yield6.20 (4.48%)
Ex-dividend date12 Jan 2024
1y target est154.21
  • Yahoo Finance Video

    AbbVie to acquire ImmunoGen in $10B deal

    Shares of ImmunoGen (IMGN), a biotechnology company focused on cancer treatments, surged Thursday afternoon on news that pharmaceutical giant AbbVie (ABBV) plans to acquire the company in a deal valued around $10 billion. Yahoo Finance's Diane King Hall and Josh Lipton break down the details of the deal. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

  • Zacks

    AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study

    Data from a mid-stage study on AbbVie's (ABBV) experimental ADC drug demonstrates compelling clinical benefits across key endpoints in certain lung cancer patients.

  • Zacks

    Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?

    Here, we discuss some reasons why investing in Harpoon Therapeutics (HARP) stock now may turn out to be a prudent move.